GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 331.44
-82.86 (-20.00%)
At close: Aug 5, 2026
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 27.68 billion as of August 5, 2026. Its market cap has increased by 620.52% in one year.
Market Cap
27.68B
Enterprise Value
27.28B
Revenue
3.73B
Ranking
n/a
PE Ratio
129.82
Stock Price
331.44
ChartMarket Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 27.68B, an increase of 4,760.80%. That is a compound annual growth rate of 20.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 27.68B | 420.72% |
| Dec 31, 2025 | 5.32B | 76.81% |
| Dec 31, 2024 | 3.01B | 1.27% |
| Dec 31, 2023 | 2.97B | -6.84% |
| Dec 29, 2022 | 3.19B | 23.58% |
| Dec 30, 2021 | 2.58B | 82.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding